Janux Therapeutics Overview
Janux Therapeutics (JANX) has a PEG ratio of 30.21, above the Healthcare sector average of 2.89.
Get informed when a big investor buys or sells
+ Follow30.21
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, JANX shows a PEG ratio of 30.21. That is above the Healthcare sector average of 2.89. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 2.89. Janux Therapeutics is at 30.21, which is higher that average. That is roughly 944.9% above the sector mean. Use the comparison chart on this page to see how JANX stacks up against individual peers as well.
Investors watch JANX's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Janux Therapeutics's latest reading is 30.21. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Janux Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 30.21) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 2.89, while JANX is at 30.21. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
